xCures announces real world biomarker study for patients with FGFR-mutant bladder cancer receiving Balversa®
xCures – A.I. for cancer patients who need help Tyra Biosciences – Precision oncology Tyra Biosciences supported study investigates if non-invasive blood and urine samples provide biomarkers to assess clinical response to erdafitinib treatment This study is a great example of how patients and their doctors have the opportunity to both better understand their options […]